Orly Vardeny
Orly Vardeny
Minneapolis VA Health Care System and University of Minnesota
確認したメール アドレス: umn.edu
タイトル
引用先
引用先
Renin–angiotensin–aldosterone system inhibitors in patients with Covid-19
M Vaduganathan, O Vardeny, T Michel, JJV McMurray, MA Pfeffer, ...
New England Journal of Medicine 382 (17), 1653-1659, 2020
16712020
Potential effects of coronaviruses on the cardiovascular system: a review
M Madjid, P Safavi-Naeini, SD Solomon, O Vardeny
JAMA cardiology 5 (7), 831-840, 2020
12322020
Influence of baseline and worsening renal function on efficacy of spironolactone in patients with severe heart failure: insights from RALES (Randomized Aldactone Evaluation Study)
O Vardeny, DH Wu, A Desai, P Rossignol, F Zannad, B Pitt, SD Solomon, ...
Journal of the American College of Cardiology 60 (20), 2082-2089, 2012
1992012
Combined neprilysin and renin-angiotensin system inhibition for the treatment of heart failure
O Vardeny, R Miller, SD Solomon
JACC: Heart Failure 2 (6), 663-670, 2014
1762014
Efficacy of sacubitril/valsartan vs. enalapril at lower than target doses in heart failure with reduced ejection fraction: the PARADIGM‐HF trial
O Vardeny, B Claggett, M Packer, MR Zile, J Rouleau, K Swedberg, ...
European journal of heart failure 18 (10), 1228-1234, 2016
1352016
Incidence, predictors, and outcomes related to hypo-and hyperkalemia in patients with severe heart failure treated with a mineralocorticoid receptor antagonist
O Vardeny, B Claggett, I Anand, P Rossignol, AS Desai, F Zannad, B Pitt, ...
Circulation: Heart Failure 7 (4), 573-579, 2014
1272014
Reduced risk of hyperkalemia during treatment of heart failure with mineralocorticoid receptor antagonists by use of sacubitril/valsartan compared with enalapril: a secondary …
AS Desai, O Vardeny, B Claggett, JJV McMurray, M Packer, K Swedberg, ...
JAMA cardiology 2 (1), 79-85, 2017
1212017
Recognition and initial management of fulminant myocarditis: a scientific statement from the American Heart Association
RD Kociol, LT Cooper, JC Fang, JJ Moslehi, PS Pang, MA Sabe, RV Shah, ...
Circulation 141 (6), e69-e92, 2020
1132020
Effects of sacubitril-valsartan versus valsartan in women compared with men with heart failure and preserved ejection fraction: insights from PARAGON-HF
JJV McMurray, AM Jackson, CSP Lam, MM Redfield, IS Anand, J Ge, ...
Circulation 141 (5), 338-351, 2020
1112020
Clinical pharmacy services in heart failure: an opinion paper from the Heart Failure Society of America and American College of Clinical Pharmacy Cardiology Practice and …
SK Milfred-LaForest, SL Chow, RJ DiDomenico, K Dracup, CR Ensor, ...
Journal of cardiac failure 19 (5), 354-369, 2013
902013
Influenza vaccination in patients with chronic heart failure: the PARADIGM-HF trial
O Vardeny, B Claggett, JA Udell, M Packer, M Zile, J Rouleau, ...
JACC: Heart Failure 4 (2), 152-158, 2016
862016
Association of influenza-like illness activity with hospitalizations for heart failure: the atherosclerosis risk in communities study
S Kytömaa, S Hegde, B Claggett, JA Udell, W Rosamond, J Temte, ...
JAMA cardiology 4 (4), 363-369, 2019
752019
Interprofessional education: principles and application a framework for clinical pharmacy
American College of Clinical Pharmacy, RL Page, AL Hume, JM Trujillo, ...
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 29 (7 …, 2009
652009
Reduced loop diuretic use in patients taking sacubitril/valsartan compared with enalapril: the PARADIGM‐HF trial
O Vardeny, B Claggett, J Kachadourian, AS Desai, M Packer, J Rouleau, ...
European journal of heart failure 21 (3), 337-341, 2019
562019
Cardiac structure and function across the glycemic spectrum in elderly men and women free of prevalent heart disease: the Atherosclerosis Risk In the Community study
H Skali, A Shah, DK Gupta, S Cheng, B Claggett, J Liu, N Bello, D Aguilar, ...
Circulation: Heart Failure 8 (3), 448-454, 2015
562015
Insulin resistance and incident heart failure: the ARIC study (Atherosclerosis Risk in Communities)
O Vardeny, DK Gupta, B Claggett, S Burke, A Shah, L Loehr, ...
JACC: Heart Failure 1 (6), 531-536, 2013
562013
Randomized Aldactone Evaluation Study (RALES) Investigators. Incidence, predictors, and outcomes related to hypo-and hyperkalemia in patients with severe heart failure treated …
O Vardeny, B Claggett, I Anand, P Rossignol, AS Desai, F Zannad, B Pitt, ...
Circ Heart Fail 7 (4), 573-579, 2014
552014
Nutrition and heart failure: impact of drug therapies and management strategies
SP Dunn, B Bleske, M Dorsch, T Macaulay, B Van Tassell, O Vardeny
Nutrition in clinical practice 24 (1), 60-75, 2009
532009
Clinical characteristics and outcomes of hospitalized women giving birth with and without COVID-19
KS Jering, BL Claggett, JW Cunningham, N Rosenthal, O Vardeny, ...
JAMA internal medicine 181 (5), 714-717, 2021
512021
The essential research curriculum for doctor of pharmacy degree programs
MW Lee, PG Clay, WK Kennedy, MJ Kennedy, NM Sifontis, D Simonson, ...
Pharmacotherapy 30 (9), 966, 2010
482010
現在システムで処理を実行できません。しばらくしてからもう一度お試しください。
論文 1–20